Peer-reviewed veterinary case report
Effectiveness of two cat vaccines after one shot against calicivirus
By Arcidiaco, Séverine et al.·Published in Vaccine·2024·Virbac, France·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Vaccines efficacy against infection with circulating feline calicivirus after one single injection: Comparison of Leucofeligen™ FeLV/RCP and Purevax™ RCPFeLV vaccines.
- Species:
- cat
Plain-English summary
A group of cats was tested to see how well two different vaccines protected them from feline calicivirus (FCV), which can make cats sick. After receiving one injection of either the Leucofeligen FeLV/RCP vaccine or the Purevax RCPFeLV vaccine, the cats were exposed to the virus three weeks later. The results showed that the Leucofeligen vaccine significantly reduced illness and the amount of virus the cats shed, while the Purevax vaccine did not provide the same level of protection. This suggests that the Leucofeligen vaccine may be more effective for protecting kittens against FCV.
People also search for: cat calicivirus vaccine effectiveness · feline calicivirus symptoms · best vaccine for kittens
Abstract
Feline calicivirus (FCV) is a worldwide pathogen that affects the general health status of cats. The aim of this study was to assess the efficacy of the FCV component of two multivalent commercial vaccines after one injection. The cats assigned to the vaccinated groups received one subcutaneous injection of either the Leucofeligen™ FeLV/RCP (Virbac, France) vaccine or the Purevax™ RCPFeLV (Boehringer Ingelheim, Germany) vaccine. In the control group, the cats did not receive any vaccine. Three weeks after the vaccine injection, all the cats were inoculated with a heterologous calicivirus strain, isolated in the field. The clinical signs of calicivirosis and the viral shedding were assessed. The results demonstrated that Leucofeligen™ FeLV/RCP could protect kittens against FCV infection by reducing clinical signs and viral excretion from 3 weeks after the first injection of primary vaccination, whereas Purevax™ RCPFeLV couldn't offer the same level of protection in similar experimental conditions.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39332239/